Can a founder claim both QSBS and Business Asset Disposal Relief on the same sale?

Not on the same slice of gain in a way that cancels both taxes automatically. QSBS is a US federal exclusion under Section 1202; BADR is a UK relief lowering the CGT rate. A dual US-UK filer is potentially within both systems at once, so each jurisdiction tests the gain separately and foreign tax credits, not double relief, usually resolve the overlap.

Does the UK tax a gain that is fully excluded under QSBS?

Potentially yes. If you are UK tax resident when you sell, HMRC generally taxes your worldwide capital gain regardless of the US QSBS exclusion. The US exclusion does not bind HMRC. This is the classic trap: a gain that is zero-taxed in the US can still attract UK capital gains tax, sometimes with no US credit available to offset it.

How does residency timing change a cross-border founder exit?

Residency at the moment of disposal usually determines which country taxes the whole gain. Selling while UK resident exposes worldwide gains to HMRC; selling while non-UK resident may remove UK exposure, subject to temporary non-residence rules. Because QSBS holding periods and BADR conditions are date-sensitive, the sale date can swing the net outcome by seven figures.

What is the QSBS holding period and why does it matter cross-border?

QSBS under Section 1202 generally requires the stock to be held for more than five years and to meet issuer and gross-asset tests at issuance. For a founder who moved between the US and UK, the clock, the company's structure, and whether shares were originally issued by a qualifying US C-corporation all determine eligibility. UK entities typically do not qualify for QSBS.

Does Business Asset Disposal Relief apply to shares in a US company?

It can, if the conditions are met. BADR generally requires a qualifying shareholding, officer or employee status, and a minimum holding period in a trading company or group. The company does not have to be UK-incorporated, but the personal company and trading tests still apply. A US C-corp can potentially qualify, subject to detailed review of the structure.

What happens to my QSBS clock if I become UK resident before selling?

Becoming UK resident does not stop the US QSBS holding period, which runs on US rules. But it changes who taxes the gain on sale. You may still qualify for the US exclusion while simultaneously facing UK CGT on the same gain. Coordinating the sale date with your residency position is central to protecting the value QSBS was meant to deliver.

How do foreign tax credits work between QSBS and BADR?

Foreign tax credits relieve double taxation only where both countries actually tax the same income. Because QSBS excludes the US gain, there may be little or no US tax to credit against a UK charge, leaving the UK liability standing. Conversely, US tax paid on a non-excluded gain may be creditable in the UK. The interaction is asymmetric and requires modelling.

Should I sell before or after leaving the UK as a founder?

It depends on your QSBS eligibility, BADR position, and future residence plans. Selling after a clean, non-temporary departure from the UK can remove HMRC's claim on the gain, but the UK temporary non-residence rules can claw back gains if you return within a set period. There is no universal answer; the right sequence is specific to your facts and treaty position.

Does the US-UK tax treaty prevent double taxation on a founder exit?

The treaty and its credit mechanisms reduce but do not always eliminate double taxation on capital gains. Gains are often taxable primarily in the country of residence, and reliefs like QSBS are unilateral US measures the treaty does not extend to the UK. Careful treaty analysis, source rules, and credit ordering are needed to avoid an unexpected combined tax bill.

What records should a founder keep to support QSBS and BADR claims?

Keep incorporation documents, the company's gross-asset position at share issuance, cap tables, evidence of your officer or employee role, share subscription and option paperwork, and dated residency records. Both the IRS and HMRC can challenge eligibility years later, and cross-border exits invite scrutiny. Contemporaneous documentation is often the difference between a defended relief and a denied one.

Can a founder claim both QSBS and Business Asset Disposal Relief on the same sale?

Not on the same slice of gain in a way that cancels both taxes automatically. QSBS is a US federal exclusion under Section 1202; BADR is a UK relief lowering the CGT rate. A dual US-UK filer is potentially within both systems at once, so each jurisdiction tests the gain separately and foreign tax credits, not double relief, usually resolve the overlap.

Does the UK tax a gain that is fully excluded under QSBS?

Potentially yes. If you are UK tax resident when you sell, HMRC generally taxes your worldwide capital gain regardless of the US QSBS exclusion. The US exclusion does not bind HMRC. This is the classic trap: a gain that is zero-taxed in the US can still attract UK capital gains tax, sometimes with no US credit available to offset it.

How does residency timing change a cross-border founder exit?

Residency at the moment of disposal usually determines which country taxes the whole gain. Selling while UK resident exposes worldwide gains to HMRC; selling while non-UK resident may remove UK exposure, subject to temporary non-residence rules. Because QSBS holding periods and BADR conditions are date-sensitive, the sale date can swing the net outcome by seven figures.

What is the QSBS holding period and why does it matter cross-border?

QSBS under Section 1202 generally requires the stock to be held for more than five years and to meet issuer and gross-asset tests at issuance. For a founder who moved between the US and UK, the clock, the company's structure, and whether shares were originally issued by a qualifying US C-corporation all determine eligibility. UK entities typically do not qualify for QSBS.

Does Business Asset Disposal Relief apply to shares in a US company?

It can, if the conditions are met. BADR generally requires a qualifying shareholding, officer or employee status, and a minimum holding period in a trading company or group. The company does not have to be UK-incorporated, but the personal company and trading tests still apply. A US C-corp can potentially qualify, subject to detailed review of the structure.

What happens to my QSBS clock if I become UK resident before selling?

Becoming UK resident does not stop the US QSBS holding period, which runs on US rules. But it changes who taxes the gain on sale. You may still qualify for the US exclusion while simultaneously facing UK CGT on the same gain. Coordinating the sale date with your residency position is central to protecting the value QSBS was meant to deliver.

How do foreign tax credits work between QSBS and BADR?

Foreign tax credits relieve double taxation only where both countries actually tax the same income. Because QSBS excludes the US gain, there may be little or no US tax to credit against a UK charge, leaving the UK liability standing. Conversely, US tax paid on a non-excluded gain may be creditable in the UK. The interaction is asymmetric and requires modelling.

Should I sell before or after leaving the UK as a founder?

It depends on your QSBS eligibility, BADR position, and future residence plans. Selling after a clean, non-temporary departure from the UK can remove HMRC's claim on the gain, but the UK temporary non-residence rules can claw back gains if you return within a set period. There is no universal answer; the right sequence is specific to your facts and treaty position.

Does the US-UK tax treaty prevent double taxation on a founder exit?

The treaty and its credit mechanisms reduce but do not always eliminate double taxation on capital gains. Gains are often taxable primarily in the country of residence, and reliefs like QSBS are unilateral US measures the treaty does not extend to the UK. Careful treaty analysis, source rules, and credit ordering are needed to avoid an unexpected combined tax bill.

What records should a founder keep to support QSBS and BADR claims?

Keep incorporation documents, the company's gross-asset position at share issuance, cap tables, evidence of your officer or employee role, share subscription and option paperwork, and dated residency records. Both the IRS and HMRC can challenge eligibility years later, and cross-border exits invite scrutiny. Contemporaneous documentation is often the difference between a defended relief and a denied one.

QSBS and UK Business Asset Disposal Relief for Founders

A dual-filing founder selling a company can face dramatically different net proceeds depending on how the US Qualified Small Business Stock (QSBS) exclusion under Section 1202 and the UK's Business Asset Disposal Relief (BADR) are sequenced and timed around residency. Get the ordering right and a nine-figure exit can be sheltered on one side and rate-reduced on the other; get it wrong and a gain excluded in the US is fully taxed in the UK.

Why the transatlantic founder exit is uniquely dangerous

For a purely domestic founder, a company sale is a single-jurisdiction event. For a US citizen living in London, a British entrepreneur who built a Delaware C-corporation, or an executive who has moved back and forth across the Atlantic, the same disposal is tested twice, under two rulebooks that were never designed to talk to each other. The United States taxes its citizens and green card holders on worldwide gains regardless of where they live. The United Kingdom taxes its residents on worldwide gains regardless of citizenship. A single sale can therefore sit inside both systems at once.

The two flagship reliefs make this worse before they make it better. QSBS can exclude a very large portion of gain from US federal tax entirely. BADR reduces the UK capital gains tax rate on qualifying business disposals. Each is generous in isolation. Neither respects the other. The US exclusion does not bind HMRC, and the UK relief does not bind the IRS. The result is that a gain fully excluded under Section 1202 can still be exposed to UK capital gains tax, sometimes with no meaningful foreign tax credit to soften the blow, because there was no US tax paid to credit.

This is why sophisticated founders treat the exit as a planning event that begins years before the term sheet, not a compliance exercise that starts after the wire clears. Our cross-border tax planning team routinely models the sale date, the residency position on that date, and the ordering of reliefs before a founder signs anything.

What is QSBS and who actually qualifies?

Qualified Small Business Stock is a US federal incentive under Internal Revenue Code Section 1202. In broad terms, it allows eligible shareholders to exclude a substantial percentage of gain on the sale of qualifying stock, subject to a per-issuer cap. To qualify, the stock must generally be issued by a domestic US C-corporation that met a gross-asset threshold at the time of issuance, the shareholder must have acquired the stock at original issue, and the stock must be held for more than five years. The company must also have used a high proportion of its assets in an active qualified trade or business during the holding period.

Several points matter intensely for cross-border founders. First, QSBS is a creature of the US C-corporation. Shares in a UK limited company, an LLP, or most non-US entities do not qualify. Second, the five-year clock runs on US rules and is unforgiving; selling at four years and eleven months can forfeit the entire exclusion. Third, the exclusion is a US measure only. It carries no weight with HMRC. A founder who assumes QSBS makes the exit tax-free everywhere is exposed to a serious surprise.

If you hold US shares and file US returns from abroad, coordinating QSBS with your broader US compliance, including any prior-year gaps, matters. Founders who fell behind while overseas should review our IRS streamlined filing guidance before an exit crystallises attention on their US position.

What is Business Asset Disposal Relief and how far does it reach?

Business Asset Disposal Relief, formerly Entrepreneurs' Relief, reduces the UK capital gains tax rate on qualifying disposals of business assets, subject to a lifetime limit on the amount of gain that can benefit. For a company sale, the seller generally must hold a qualifying shareholding, be an officer or employee, and the company must be a trading company or the holding company of a trading group, with these conditions met throughout a minimum qualifying period ending with the disposal.

Crucially, BADR does not require the company to be UK-incorporated. A US C-corporation can, in principle, be a qualifying company for BADR if the personal company and trading tests are satisfied. This is the overlap zone: the very same Delaware C-corp shares that qualify for QSBS in the US may also support a BADR claim in the UK. That does not mean both reliefs stack to eliminate tax. It means both systems have a claim on the gain, and the reliefs operate independently within each.

The lifetime limit on BADR has changed over the years and the qualifying rate is subject to legislative adjustment, so any founder relying on it should confirm the current figures with an adviser rather than assume the numbers from an older exit. Our UK tax services team tracks these thresholds closely because a founder's model can move by hundreds of thousands of pounds on a rate change alone.

QSBS versus BADR at a glance

Feature	US QSBS (Section 1202)	UK BADR
Nature of relief	Exclusion of gain from tax	Reduced CGT rate on gain
Qualifying entity	US domestic C-corporation only	Trading company or group; not restricted to UK companies
Holding period	More than five years (US rules)	Minimum qualifying period ending with disposal
Personal condition	Acquired stock at original issue	Officer or employee with qualifying shareholding
Cap	Per-issuer exclusion cap	Lifetime limit on qualifying gains
Binds the other country?	No effect on HMRC	No effect on the IRS
Who is taxed	US citizens, green card holders, US residents	UK residents (worldwide gains)

How does residency timing decide the outcome?

For a dual-filer, the single most powerful variable is usually the residency position on the date of disposal. The UK generally taxes the worldwide gains of a person who is UK resident in the tax year of sale. So a founder who is UK resident when the shares are sold exposes the entire gain to HMRC, even if QSBS wipes out the US tax. Conversely, a founder who has genuinely ceased UK residence before selling may fall outside the UK charge on the gain, subject to the anti-avoidance rules described below.

Because QSBS eligibility depends on a five-year US clock and BADR depends on a qualifying period ending with the disposal, the founder is often threading two date-sensitive needles at once. Selling too early can forfeit QSBS. Selling while still UK resident can hand HMRC the whole gain. Selling immediately after departure can trigger the temporary non-residence rules. The optimal sequence is rarely obvious and almost never the same for two founders with different facts.

The temporary non-residence trap

The UK has anti-avoidance rules designed to stop people leaving, selling assets during a short absence, and returning tax-free. In broad terms, if you were UK resident for enough of the prior years, leave, realise gains during a period of non-residence, and then return within a defined window, certain gains can be brought back into charge in the year of your return. This means a hurried departure timed to a sale can fail if you later move back to the UK. Genuine, durable changes of residence are treated very differently from short tactical absences.

The exit tax and mark-to-market question

US citizens contemplating expatriation, and long-term residents giving up a green card, face their own regime that can deem assets sold at fair value on exit. Founders sitting on large unrealised gains who are considering renouncing US status must model this carefully, because a deemed disposal can crystallise gain before a real buyer ever appears. This is a specialist area where the interaction with QSBS is subtle and the stakes are high.

Worked scenarios: how sequencing changes the number

Consider three stylised founders. None of these is advice; each shows why the sequence matters.

The US founder in London. A US citizen holds QSBS-eligible Delaware C-corp shares and is UK tax resident. She sells while resident. The US excludes most of the gain under Section 1202, so there is little US tax. But HMRC taxes the worldwide gain, and because there is minimal US tax to credit, the UK liability largely stands. The QSBS benefit is effectively neutralised by the UK charge.
The British founder of a Delaware company. A UK-domiciled founder built a US C-corp, meets BADR conditions, and is not a US taxpayer. On sale, the UK applies BADR's reduced rate; the US may tax the gain to the extent it is US-source or otherwise within US jurisdiction, but a non-US person's capital gain on stock is frequently outside the US net. Here BADR does real work and the US exposure may be limited.
The returning executive. A founder leaves the UK, becomes non-resident, sells during a genuine long-term absence, and does not return within the temporary non-residence window. The UK charge may fall away entirely, while QSBS shelters the US side. This is the cleanest outcome, but it depends on a real, durable relocation, not a paper move.

The gap between the first and third founder can be enormous on the same underlying gain. That gap is created almost entirely by timing and residency, not by the reliefs themselves. This is the heart of high-net-worth exit planning.

How do foreign tax credits reconcile the two systems?

Founders often assume that double tax treaties and foreign tax credits will smooth everything out. They help, but they are not a cure. Foreign tax credits relieve double taxation only where both countries actually tax the same income. QSBS creates an asymmetry: by excluding the US gain, it removes the US tax that would otherwise have been creditable against a UK charge. The UK still taxes the gain, but there is little or no US tax to credit, so the UK liability is not offset. The relief that made the US side efficient is precisely what leaves the UK side exposed.

The reverse can also be true. Where a founder does pay US tax on a non-excluded gain, that US tax may be creditable in the UK, reducing the net UK cost. Credit ordering, the source of the gain, and the treaty's rules on which country has primary taxing rights all feed into the result. Because the interaction is asymmetric and fact-specific, it must be modelled numerically before the sale, not assumed. Our US-UK tax accountants build this model for founders as a matter of course.

Structuring the exit before the term sheet

The most valuable planning happens long before a buyer appears. Once a deal is in motion, options narrow quickly. Considerations that reward early attention include:

Entity choice at inception. QSBS demands a US C-corporation. Founders who plan a US exit but incorporate elsewhere, or convert too late, can forfeit the exclusion. The structure chosen years earlier constrains the reliefs available at exit.
Documenting the holding period and issuance facts. QSBS requires proof that the company met the gross-asset test at issuance and that shares were acquired at original issue. Contemporaneous records are far stronger than reconstructed ones.
Officer or employee status for BADR. BADR requires a qualifying role throughout the relevant period. Founders who step back from formal roles too early can lose the relief.
Residency planning around the sale. Where and when you are resident on the disposal date can be the single largest lever, subject to the temporary non-residence rules.
Estate and wealth structuring. A large liquidity event reshapes the estate. Trusts, gifting, and cross-border succession planning are best addressed alongside the exit, not afterwards. See our work on trusts and estate planning.

Common mistakes that cost founders millions

Across cross-border exits, the same errors recur. Assuming QSBS makes the sale tax-free everywhere. Selling a few months short of the five-year clock. Timing a UK departure so tightly to a sale that the temporary non-residence rules apply. Treating the treaty as an automatic shield. Losing BADR by resigning a directorship too early. Failing to keep the issuance and gross-asset records that QSBS demands. Each of these is avoidable with planning, and each is very difficult to fix once the deal has closed.

There is also a compliance dimension. A large exit draws attention to a founder's entire filing history on both sides. Undisclosed foreign accounts, missed returns, or informational reporting gaps can surface at the worst possible moment. Founders with historic gaps should address them proactively; our US tax services and private client tax services teams handle this discreetly ahead of a transaction.

A practical sequencing checklist

Confirm QSBS eligibility: US C-corp, original issue, gross-asset test, five-year clock, active business use.
Confirm BADR eligibility: qualifying shareholding, officer or employee status, trading company, qualifying period.
Fix your residency position on the intended disposal date and stress-test it against the temporary non-residence rules.
Model the foreign tax credit outcome, recognising the QSBS asymmetry that can leave a UK charge unrelieved.
Assemble documentation now: cap table, incorporation and gross-asset evidence, role history, dated residency records.
Layer in estate, trust, and succession planning before, not after, the wire arrives.

Speak to specialists before you sign

A cross-border founder exit is one of the few moments where a single decision, the sale date, the residency position, the sequence of reliefs, can move the after-tax result by seven or eight figures. QSBS and BADR are powerful, but they were built by different governments for different purposes, and their interaction rewards planning and punishes assumption. If you are approaching a liquidity event on either side of the Atlantic, or you hold QSBS-eligible shares and are unsure how a UK move affects them, speak to us before you commit to a structure or a timeline. Arrange a confidential consultation with Jungle Tax and let our cross-border specialists model your exit so the value you built is the value you keep.